DPC 684
Latest Information Update: 24 Jun 2004
At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections